Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus sufentanil as epidural adjuvants for labor analgesia
IRCT20260521069470N1Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Jun 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in labor pain comparing Ropivacaine + sufentanil with Ropivacaine + dexmedetomidine (2 arms). Primary endpoints: Pain intensity by visual analog scale, Analgesia duration and 2 more. Started Jun 2026; status: completed.
02
Drugs
dexmedetomidinesufentanilropivacaine
03
Conditions
labor pain
Beyond the preview
Go deeper on IRCT20260521069470N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260521069470N1.